« Back to Record
Citation APA

Desmedt, C., de Azambuja, E., Larsimont, D., Delaloge, S., Duhem, C., Rouas, G., Di Leo, A., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2008). Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients. J Clin Oncol. Vol. 26: May 20 suppl; (p. abstr 11065) ASCO - American Society of Clinical Oncology Annual Meeting(2008: Chicago, IL, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/245199

Desmedt, C., de Azambuja, E., Larsimont, D., Delaloge, S., Duhem, C., Rouas, G., Di Leo, A., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2008). Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients. J Clin Oncol. Vol. 26: May 20 suppl; (p. abstr 11065) ASCO - American Society of Clinical Oncology Annual Meeting(2008: Chicago, IL, USA).